NUTXHealthcare · Medical Care FacilitiesThe 5 Wall Street analysts covering Nutex Health, Inc. hold a median 12-month price target of $290 — +55.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 88 of 100 as at 22 Aug 2026 — inside the top quartile. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Nutex Health, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Quality (99): The business earns solid, repeatable profits on what it owns.
Volatility (11): The share price moves around a lot.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on NUTX, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +55.5% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 11 Aug 2026 | Lake Street | Maintains | Buy | $235 → $310 |
| 26 June 2026 | B. Riley Securities | Initiates | Buy | $290 |
| 26 June 2026 | B. Riley Securities | Initiates | Buy | — |
| 2 June 2026 | Lake Street | Initiates | Buy | — |
| 26 Aug 2025 | Maxim Group | Maintains | Buy | — |
| 10 July 2025 | Benchmark | Reiterates | Buy | — |
| 20 May 2025 | Maxim Group | Maintains | Buy | — |
| 15 May 2025 | Benchmark | Maintains | Buy | — |
| 9 Apr 2025 | Benchmark | Maintains | Buy | — |
| 8 Apr 2025 | Maxim Group | Maintains | Buy | — |
| 13 Feb 2025 | Maxim Group | Maintains | Buy | — |
| 12 Nov 2024 | Benchmark | Maintains | Buy | — |
| 12 Nov 2024 | Maxim Group | Maintains | Buy | — |
| 18 Sept 2024 | Maxim Group | Initiates | Buy | — |
| 21 Aug 2024 | Benchmark | Maintains | Buy | — |
| 25 Jan 2024 | Benchmark | Maintains | Buy | — |
| 14 Nov 2023 | Benchmark | Maintains | Buy | — |
| 29 Aug 2023 | Benchmark | Reiterates | Buy | — |
| 17 May 2023 | Benchmark | Maintains | Buy | — |
| 9 Mar 2023 | Benchmark | Reiterates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. NUTX appears on the weeks it earns a place.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 63% of US stocks
Cheaper than 60% of US stocks
Cheaper than 29% of US stocks
Cheaper than 56% of US stocks
Higher than 13% of US stocks
Higher than 23% of US stocks
Higher than 80% of US stocks
Higher than 98% of US stocks
Higher than 83% of US stocks
Higher than 94% of US stocks
Higher than 99% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Nutex Health, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Nutex Health announced the opening of its 28th hospital nationwide, West Little Rock Emergency Hospital, located at 17810 Chenal Parkway in Little Rock, Arkansas. This is the company's third facility in the state.
Why it matters — The opening expands Nutex Health's hospital network and geographic footprint, adding a new facility in Arkansas as part of its nationwide growth.
Nutex Health was upgraded to "Strong Buy" by Seeking Alpha, citing margin expansion and patient volume growth. Q2 featured 9.6% patient volume growth despite a 13% year-over-year revenue decline, alongside significant operating cost reductions; CMS administrative fee cuts and the HaloMD contract amendment are expected to lower normalized costs by 25%–30% in future periods.
Why it matters — A NUTX watcher would care because the upgrade and expected cost reductions from regulatory and contractual changes signal improving profitability prospects for the company.
Seeking Alpha published a transcript of Nutex Health Inc.'s Q2 2026 earnings call, covering the company's quarterly results and management commentary.
Why it matters — A Q2 earnings call transcript offers Nutex Health watchers direct insight into the company's recent financial performance and management's outlook.
Nutex Health reported higher second-quarter profitability and adjusted EBITDA despite lower revenue, benefiting from reduced arbitration-related costs, lower stock-based compensation, and continued patient-volume growth.
Why it matters — A NUTX watcher would care because improved profitability and adjusted EBITDA despite lower revenue signal stronger underlying operational performance and cost management.
Nutex Health announced its financial results for the three and six months ended June 30, 2026. The company operates 27 hospital facilities across 12 states, along with a primary care-centric, risk-bearing physician network.
Why it matters — The quarterly results provide NUTX watchers with an update on the financial performance of the company's hospital and physician network operations.
The 5 Wall Street analysts covering Nutex Health, Inc. have a median 12-month price target of $290, with estimates ranging from $200 to $310. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 5 analysts covering Nutex Health, Inc., 5 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Nutex Health, Inc. 88 out of 100 across roughly 4,600 US stocks as at 22 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 22 Aug 2026, Nutex Health, Inc. ranks 88 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Quality (99 of 100).
No one can know that. What the data says: the median 12-month target from 5 analysts implies +55.5% from the last close, and Ticker Nerd's factor model ranks Nutex Health, Inc. 88 out of 100 as at 22 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Nutex Health, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for NUTX are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $200 to $310 over the next 12 months.
Nutex Health, Inc. returned +93.9% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
Nutex Health Inc. is a physician-led, technology-enabled healthcare management and operations company headquartered in Houston, Texas, founded in 2011.
The most recent item we track (PRNewsWire, 18 Aug 2026): "NUTEX HEALTH OPENS WEST LITTLE ROCK EMERGENCY HOSPITAL IN ARKANSAS". Nutex Health announced the opening of its 28th hospital nationwide, West Little Rock Emergency Hospital, located at 17810 Chenal Parkway in Little Rock, Arkansas. This is the company's third facility in the state.
Nutex Health Inc. is a physician-led, technology-enabled healthcare management and operations company headquartered in Houston, Texas, founded in 2011. It operates through three primary segments: the Hospital Division, Population Health Management Division, and Real Estate Division. The Hospital Division develops and manages innovative care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs), providing 24/7 emergency, inpatient, behavioral health, imaging, laboratory, and pharmacy services across over 24 facilities in 11 states. The Population Health Management Division oversees provider networks like Independent Physician Associations (IPAs) and delivers management services through its Management Services Organizations (MSOs), supported by a cloud-based platform that aggregates clinical and claims data for efficient, holistic patient care. The Real Estate Division owns and leases land and buildings to hospital entities. Nutex Health Inc. plays a significant role in the healthcare facilities and services sector by offering cost-effective, high-quality alternatives to traditional hospitals, enhancing access to specialized emergency and outpatient care while aligning with physicians for value-based delivery.
CEO Dr. Thomas T. Vo M.B.A., M.D. · 1,037 employees · United States · https://www.nutexhealth.com